За горами – горы. История врача, который лечит весь мир
Шрифт:
Farmer, P E., Rylko-Bauer, B. L. L’exceptionnel systeme de sante americain: Critique d’une medecine a vocation commerciale. Actes de la recherche en Sciences sociales 2001; 139: 13–30.
Farmer, P. E., Smith-Fawzi, M. C., Nevil, P Unjust embargo of aid for Haiti. Lancet 2003; 361: 420–423.
Farmer, P E., Walton, D., Tarter, L. Infections and inequalities. Global Change and Human Health 2000; 1 (2): 94-109.
Furin, J. J., Mitnick, C., Shin, S. S., Bayona, J., Becerra, M., SlNGLER, J., ALCBNTARA, F., CASTANEDA, C., Sanchez, E., Acha, J., Farmer, P E., Kim, J. Y. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. International Journal for Tuberculosis and Lung Disease 2001;
Furin, J. J., Becerra, M. C., Shin, S. S., Kim, J. Y., Bayona, J., Farmer, P. E. Effect of administering short-course, standard regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. European Journal of Clinical Microbiology and Infectious Diseases 2000; 19 (1): 132–136.
Furin, J. J., Mitnick, C. D., Becerra, M., Shin, S. S., Singler, J. M., Bayona, J., AlcAntara, F., Sanchez, E., Bomann, M., Kim, J. Y., Farmer, P E. Absence of serious adverse effects in a cohort of Peruvian patients receiving community-based treatment for multidrug-resistant tuberculosis (MDR-TB). International Journal of Tuberculosis and Lung Disease 1999; 3 (9 supp. 1): S81.
Gaines, A., Farmer, P E. Visible saints: Social cynosures and dysphoria in the Mediterranean tradition. Culture, Medicine, and Psychiatry 1986; 10 (4): 295–330.
Gupta, R., Kim, J. Y., Espinal, M. A., Caudron, J.-M., Pecoul, B., Farmer, P E., Raviglione, M. C. Responding to market failures in tuberculosis control. Science 2001; 293: 1049-51.
Kim, J. Y., Furin, J. J., Shakow, A. D., Millen, J. V, Brenner, J. G., Fordyce, M. W., Lyon, E., Bayona, J., Farmer, P. E. Treatment of multidrugresistant tuberculosis (MDR-TB): New strategies for procuring second– and third-line drugs. International Journal of Tuberculosis and Lung Disease 1999; 3 (9 supp. 1): S81.
Miranda, J., Farmer, P E. Social exclusion must be considered in global terms. British Medical Journal 2001; 323: 1370.
Mitnick, C., Bayona, J., Palacios, E., Shin, S. S., Furin, J. J., AlcAntara, F., SA nchez, E., Sarria, M., Becerra, M., Smith-Fawzi, M. C., Kapiga, S., Neuberg,
D., Maguire, J. H., Kim, J. Y., Farmer, P E. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine 2003; 348 (2): 119–128.
Mukherjee, J. S., Shin, S. S., Furin, J. J., Rich, M. L., Leandre, F., Joseph, K. J., Seung, K., Acha, J., Gelmanova, I., Goncharova, E., Pasechnikov, A., Vir u, F. A., Farmer, P. E. New challenges in the clinical management of drug-resistant tuberculosis. Infectious Diseases in Clinical Practice.
Rylko-Bauer, B., Farmer, P. E. Managed care or managed inequality? A call for critiques of market-based medicine. Medical Anthropology Quarterly 2002; 16 (4): 476–502.
Singler, J., Farmer, P E. Treating HIV in resource-poor settings. MSJAMA 2002; 288: 1652–1653.
Timperi, R., Sloutsky, A., Farmer, P. E. Global laboratory testing capacity for tuberculosis. International Journal of Tuberculosis and Lung Disease 1998; 2 (11 supp. 2): S290-291.
Другое
Farmer, P E. Social medicine and the challenge of bio-social research. In Innovative Structures in Basic Research: Ringberg-Symposium 4–7 October 2000. Plehn, G. (ed.). Munich: Gene-ralverwaltung der Max-Planck-Gesellschaft, Referat fkr Presse-und Offentlichkeitsarbeit, pp. 55–73. Available atmpiwg-berlin.mpg.de/ringberg/main.html.
Farmer, P. E. Prevention without treatment is not sustainable. National AIDS Bulletin (Australia) 2000; 13 (6): 6–9, 40.
Farmer, P E. What is appropriate empiric therapy for active tuberculosis? Ask the Expert. APUA Newsletter 2000; 18 (3): 6.
Farmer, P E. AIDS heretic. New Internationalist Jan. – Feb. 2001; 331: 14–16.
Farmer, P E. Arresting global epidemics: Are some people too poor to treat? GSAS Newsletter (Harvard University) 2001: 4–5, 12–13.
Farmer, P. E. Use of antiretroviral therapy in developing countries: A biosocial analysis. Abstracts of the 10th Conference on Retroviruses and Opportunistic Infections, Boston, 2003, session 92, abstract 48, p. 4.
Farmer, P. E., Castro, A. Un pilote en Haiti: De l”efficacite de la distribution d”antiviraux dans des pays pauvres, et des objections qui lui sont faites. Vacarme Apr. 2002; 19: 17–22.
Farmer, P E., Castro, A. Castigo a los mas pobres de America. El Pais, Jan. 12, 2003, p. 8–9.
Farmer, P E., Castro, A. Urgence humanitaire en Haiti. Courrier International 2003; 640: 20–21.
Farmer, P E., Leandre, F., Bayona, J., Louissaint, M. DOTS-Plus for the poorest of the poor: The Partners In Health experience in Haiti. International Journal of Tuberculosis and Lung Disease 2001; 5 (11): S257.
Farmer, P. E., Leandre, F., Koenig, S. P., Nevil,
P. Mukherjee, J., Ferrer, J., Walker, B., Ore lus, C., Smith-Fawzi, M. C. Preliminary outcomes of directly observed treatment of advanced HIV disease with ARVs (DO-THAART) in rural Haiti. Abstracts of the 10th Conference on Retroviruses and Opportunistic Infections, Boston, 2003, session 33, abstract 171, p. 120.
Naroditskaya, V, Werner, B. G., Farmer, P. E., Becerra, M., Sloutsky, A. Limited mutation pattern found by DNA sequence analysis of rifampinresistant (rif-R) clinical Mycobacterium tuberculosis isolates from Peru. Abstracts of the Annual Meeting of the American Society of Microbiology, Chicago, Ill., 1999, session 27U, abstract U-11, p. 635.
Walton, D., Farmer, P E. The new white plague. MSJAMA (online), 2000, 284 (21): 2789.
Мне